WallStSmart
NNNN

Anbio Biotechnology Class A Ordinary Shares

NASDAQ: NNNN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$11.59
+14.19% today

Updated 2026-07-29

Market cap
$513.53M
P/E ratio
78.00
P/S ratio
59.39x
EPS (TTM)
$0.15
Dividend yield
52W range
$11 – $56
Volume
0.0M

Anbio Biotechnology Class A Ordinary Shares (NNNN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 3
Last 3 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
Most recent quarter

When is the next earnings report?

Reporting date
June 30, 2026
Consensus EPS estimate
Fiscal period ending
2026-06-30

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-7.2%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-7.2%
2025-12-30
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-30$0.09$32.39$30.07-7.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-06-30
2025-09-30$0.00$0.09$2.03M
2025-03-31$0.00$-0.03
2024-09-30$0.00$0.09

Frequently asked questions

When does Anbio Biotechnology Class A Ordinary Shares report next earnings?

Anbio Biotechnology Class A Ordinary Shares (NNNN) is scheduled to report earnings on June 30, 2026.

Has Anbio Biotechnology Class A Ordinary Shares beaten earnings estimates?

Anbio Biotechnology Class A Ordinary Shares has beaten Wall Street EPS estimates in 2 of its last 3 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does NNNN stock react to earnings?

NNNN has moved an average of -7.2% the day after earnings over its last 1 reports, finishing higher after 0 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.